Crumlin-based BBI Solutions has been announced as part of a consortium of the UK’s top diagnostic companies to rapidly develop and rollout a new coronavirus antibody test.
The biotech firm is now a part of the UK Rapid Test Consortium which includes Oxford University and others.
All existing antibody tests that have gone through the validation process have not proven accurate enough. The UK Government is backing efforts to develop a home-grown test.
BBI Group CEO Dr Mario Gualano said: “Utilising the resources and expertise across BBI Solutions’ global business, we are moving quickly and effectively to seek solutions.”